| |
| |
| |
| Molecular Genetics and Neurologic Disease: An Introduction | |
| |
| |
| |
| A Neurologic Gene Map | |
| |
| |
| |
| Finding and Excluding Gene Locations by Linkage Analysis | |
| |
| |
| |
| Gene Targeting | |
| |
| |
| |
| Down Syndrome | |
| |
| |
| |
| Fragile X Syndrome | |
| |
| |
| |
| Molecular Biology of Prion Diseases | |
| |
| |
| |
| Clinical and Neuropathologic Features of Prion Diseases | |
| |
| |
| |
| Inherited Prion Diseases | |
| |
| |
| |
| The Mitochondrial Genome | |
| |
| |
| |
| Mitochondrial Encephalomyelopathies | |
| |
| |
| |
| Mitochondrial Mechanisms of Aging | |
| |
| |
| |
| Peroxisomal Disorders | |
| |
| |
| |
| Refsum Disease | |
| |
| |
| |
| The Mucopolysaccharidoses and the Mucolipidoses | |
| |
| |
| |
| Disorders of Glycoprotein Degradation | |
| |
| |
| |
| Wolman Disease | |
| |
| |
| |
| Ceramidase Deficiency: Farber Lipogranulomatoses | |
| |
| |
| |
| The Niemann-Pick Disease Group | |
| |
| |
| |
| Glucosyceramide Lipidosis: Gaucher Disease | |
| |
| |
| |
| Krabbe Disease (Globoid Cell Leukodystrophy) | |
| |
| |
| |
| Metachromatic Leukodystrophy and Multiple Sulfatase Deficiency | |
| |
| |
| |
| Fabry Disease: Alpha-Galactosidase A Deficiency | |
| |
| |
| |
| Schindler Disease: Deficient Alpha-N-Acetylgalactosamindase Activity | |
| |
| |
| |
| Beta-Galactosidase Deficiency: GM1 Gangliosidosis, Morquio B Disease, and Galactosialidosis | |
| |
| |
| |
| The GM2 Gangliosidoses | |
| |
| |
| |
| Canavan Disease | |
| |
| |
| |
| The Hereditary Ataxias | |
| |
| |
| |
| Huntington Disease | |
| |
| |
| |
| Inherited Disorders of the Basal Ganglia | |
| |
| |
| |
| Alzheimer Disease: Clinical and Genetic Features | |
| |
| |
| |
| Cellular and Molecular Biology of Amyloid and Alzheimer Disease | |
| |
| |
| |
| Cellular and Molecular Biological Aspects of Tau and Alzheimer Disease | |
| |
| |
| |
| Inherited Multiple Sclerosis | |
| |
| |
| |
| Oncogenes and Neuro-Oncology | |
| |
| |
| |
| Tumors of Neuronal Cell Origin | |
| |
| |
| |
| Tumor Suppressor Genes and the Nervous System | |
| |
| |
| |
| The Clinical and Molecular Genetics of Neurofibromitosis I and II | |
| |
| |
| |
| Myotonia Congenita | |
| |
| |
| |
| The Periodic Paralyses | |
| |
| |
| |
| Malignant Hyperthermia and Central Core Disease | |
| |
| |
| |
| Episodic Ataxia and Myokymia | |
| |
| |
| |
| Genetic Epilepsies | |
| |
| |
| |
| Spinal Muscular Atrophy | |
| |
| |
| |
| Inherited ALS | |
| |
| |
| |
| Inherited Demyelinating Neuropathy | |
| |
| |
| |
| Inherited Axonal Neuropathy | |
| |
| |
| |
| Familial Amyloidotic Neuropathy | |
| |
| |
| |
| Congenital Myopathies | |
| |
| |
| |
| Dystrophinopathies | |
| |
| |
| |
| Myotonic Dystrophy | |
| |
| |
| |
| Facioscapulohumeral and Limb-Girdle Muscular Dystrophies | |
| |
| |
| |
| Lipid Disorders of Muscle | |
| |
| |
| |
| Xeroderma Pigmentosum | |
| |
| |
| |
| Tuberous Sclerosis | |
| |
| |
| |
| Incontinentia Pigmenti | |
| |
| |
| |
| Disorders of Lipoproteins | |
| |
| |
| |
| Genetics of Apolipoprotein E | |
| |
| |
| |
| The Chemistry of Apolipoprotein E | |
| |
| |
| |
| Cerebrotendinous Xanthomatosis | |
| |
| |
| |
| Disorders of Carbohydrate Metabolism: Glycogen Storage Diseases | |
| |
| |
| |
| Disorders of Galactose Metabolism | |
| |
| |
| |
| Molecular Biology of Alcohol Dependence | |
| |
| |
| |
| Inborn Errors of Amino Acid Metabolism and Transport | |
| |
| |
| |
| Urea Cycle Disorders | |
| |
| |
| |
| Maple Syrup Disease | |
| |
| |
| |
| Glutathione in the Brain: Disorders of Glutathione Metabolism | |
| |
| |
| |
| Lesch-Nyhan Disease and HPRT Deficiency | |
| |
| |
| |
| The Porphyrias | |
| |
| |
| |
| Disorders of Copper Metabolism | |
| |
| |
| |
| Hallervordern-Spatz Disease | |
| |
| |
| |
| Inherited Disorders of Colbalmin and Folate Transport and Metabolism | |
| |
| |
| |
| Disorders of Biotin Metabolism: Treatable Neurologic Syndromes | |
| |
| |
| |
| The Genetics of Bipolar Neurologic Disease | |
| |
| |
| |
| Gene Therapy and Neurologic Disease | |
| |
| |
| |
| Consequences of Mapping and Sequencing the Human Genome for Neurologic Diseases | |